NCT07165938

Brief Summary

Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
114mo left

Started Feb 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Feb 2026Sep 2035

First Submitted

Initial submission to the registry

September 3, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 10, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

February 4, 2026

Completed
9.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2035

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2035

Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

9.6 years

First QC Date

September 3, 2025

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic yield

    The diagnostic yield of genomic sequencing will be calculated as the percentage of enrolled participants with NE who receive a genetic diagnosis.

    10 years

Study Arms (1)

Neonatal Encephalopathy

Individuals with a history of NE who are less than 6 years old at the time of enrollment and available biological parents. Must be followed clinically at Boston Children's Hospital. Research genomic sequencing with CLIA confirmation of diagnostic findings. Those with an existing genetic diagnosis or who are deceased prior to enrollment are ineligible.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at Boston Children's Hospital and available biological parents

You may qualify if:

  • Diagnosed with neonatal encephalopathy during the neonatal period as documented in the electronic medical record
  • Less than 6 years old at the time of study enrollment
  • Patient at Boston Children's Hospital

You may not qualify if:

  • Genetic cause of NE already identified
  • Deceased prior to enrollment
  • Parent criteria:
  • \- Biological parent of eligible proband (see above)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

DNA, blood, saliva, buccal, tissue samples

MeSH Terms

Conditions

Hypoxia-Ischemia, Brain

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Pediatrics

Study Record Dates

First Submitted

September 3, 2025

First Posted

September 10, 2025

Study Start

February 4, 2026

Primary Completion (Estimated)

September 1, 2035

Study Completion (Estimated)

September 1, 2035

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

De-identified clinical and genomic data may be shared with approved researchers at Boston Children's Hospital and with approved external collaborators.

Locations